Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Programmed Cell Death 1 Ligand 1(PDL1, PD-L1)”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableUnknownNCT04405661
What this trial is testing

Correlation Between Specific Gene Mutationand Local Immune Microenvironment and Immunotherapy Efficacy in NSCLC

Who this might be right for
NSCLC
Guangzhou Institute of Respiratory Disease 100
Large-scale testing (Phase 3)Active Not RecruitingNCT04547504
What this trial is testing

PEmbRolizumab verSus chEmotherapy and pEmbrolizumab in Non-small-cell Lung Cancers (NSCLC) With PDL1 ≥ 50 %

Who this might be right for
Non-small-cell Lung Cancer
University Hospital, Brest 349
Early research (Phase 1)Looking for participantsNCT06066138
What this trial is testing

Therapeutic Drug Monitoring-Based Atezolizumab Dosing

Who this might be right for
Locally Advanced Alveolar Soft Part SarcomaMetastatic Alveolar Soft Part SarcomaLocally Advanced Non Small Cell Lung Cancer+7 more
National Cancer Institute (NCI) 30
Testing effectiveness (Phase 2)UnknownNCT05603013
What this trial is testing

Vinorelbine Metronomic Chemotherapy Combined With Hypofractionated Radiotherapy, PD-1/PD-L1 Sequential GM-CSF and IL-2 for Treatment of Advanced Refractory Non-small Cell Lung Cancer and Breast Cancer(PRaG 6.0)

Who this might be right for
Carcinoma, Non-Small-Cell LungCarcinoma Breast
Second Affiliated Hospital of Soochow University 45
Testing effectiveness (Phase 2)Active Not RecruitingNCT03601455
What this trial is testing

Radiation Therapy and Durvalumab With or Without Tremelimumab in Treating Participants With Unresectable, Locally Advanced, or Metastatic Bladder Cancer

Who this might be right for
Bladder Urothelial CarcinomaStage IV Bladder Cancer AJCC v8Stage IVA Bladder Cancer AJCC v8+1 more
Jonsson Comprehensive Cancer Center 13
Not applicableUnknownNCT04984148
What this trial is testing

Construction of CT Radiomics Model for Predicting the Efficacy of Immunotherapy in Patients With Stage III NSCLC

Who this might be right for
Stage III Non-small Cell Lung Cancer
Guangdong Provincial People's Hospital 70
Early research (Phase 1)Study completedNCT03812549
What this trial is testing

Safety and Tolerability Evaluation of Sintilimab in Combination With Radiation in Stage IV NSCLC Patients

Who this might be right for
Stage IV NSCLC
Sichuan University 29
Not applicableTemporarily pausedNCT04025515
What this trial is testing

Molecular Profiling Project

Who this might be right for
Lung CancerNon-Small Cell Lung Cancer
National Cancer Centre, Singapore 500
Large-scale testing (Phase 3)Study completedNCT04799249
What this trial is testing

Trilaciclib, a CDK 4/6 Inhibitor, in Patients Receiving Gemcitabine and Carboplatin for Metastatic Triple-Negative Breast Cancer (TNBC)

Who this might be right for
TNBC - Triple-Negative Breast CancerBreast Cancer
G1 Therapeutics, Inc. 194
Not applicableUnknownNCT04191226
What this trial is testing

Genetic Mutation in Recurrent Cervical Cancer

Who this might be right for
Recurrent Cervical CancerNucleotide VariantCopy Number Variation+6 more
Lei Li 300
Large-scale testing (Phase 3)Active Not RecruitingNCT05382299
What this trial is testing

Study of Sacituzumab Govitecan-hziy Versus Treatment of Physician's Choice in Patients With Previously Untreated Locally Advanced Inoperable or Metastatic Triple-Negative Breast Cancer

Who this might be right for
Triple Negative Breast CancerPD-L1 Negative
Gilead Sciences 623
Large-scale testing (Phase 3)Study completedNCT03924856
What this trial is testing

Perioperative Pembrolizumab (MK-3475) Plus Neoadjuvant Chemotherapy Versus Perioperative Placebo Plus Neoadjuvant Chemotherapy for Cisplatin-eligible Muscle-invasive Bladder Cancer (MIBC) (MK-3475-866/KEYNOTE-866)

Who this might be right for
Bladder Cancer
Merck Sharp & Dohme LLC 907
Not applicableUnknownNCT05964595
What this trial is testing

Temporal Diffusion Spectroscopy MRI in Predicting the CPS of PD-L1 Expression and the Efficacy of Neoadjuvant Therapy

Who this might be right for
Head and Neck Squamous Cell CarcinomaMagnetic Resonance ImagingNeoadjuvant Therapy
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University 136
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07819019
What this trial is testing

A Phase II Study of Irinotecan Liposome Plus Fruquintinib and Sintilimab in Second-Line PD-L1-Positive Advanced Gastric Cancer

Who this might be right for
Stomach NeoplasmsGastric Cancer
Cancer Hospital Chinese Academy of Medical Science, Shenzhen Center 20
Testing effectiveness (Phase 2)WithdrawnNCT06328036
What this trial is testing

Testing the Combination of Anti-cancer Drugs Tiragolumab and Atezolizumab to Improve Outcomes for Patients With Recurrent Glioblastoma

Who this might be right for
Recurrent Glioblastoma, IDH-Wildtype
National Cancer Institute (NCI)
Testing effectiveness (Phase 2)Looking for participantsNCT05144698
What this trial is testing

RAPA-201 Therapy of Solid Tumors

Who this might be right for
Solid TumorSmall Cell and Non-small Cell Lung CancerHead and Neck Cancer+6 more
Rapa Therapeutics LLC 37
Testing effectiveness (Phase 2)WithdrawnNCT02143804
What this trial is testing

Safety and Efficacy of CG0070 Oncolytic Virus Regimen in Patients With High Grade Non-Muscle Invasive Bladder Cancer

Who this might be right for
Bladder CancerHigh GradeNon Muscle Invasive
CG Oncology, Inc.
Testing effectiveness (Phase 2)Study completedNCT02574598
What this trial is testing

MK-3475 in Combination With Docetaxel vs Docetaxel Alone in Non-Small Cell Lung Cancer Patients

Who this might be right for
Carcinoma, Non-Small-Cell Lung
Instituto Nacional de Cancerologia de Mexico 78
Testing effectiveness (Phase 2)Ended earlyNCT04131634
What this trial is testing

Stereotactic Ablative Radiation for Oligo-Progression of Urothelial Cancer

Who this might be right for
Urothelial Cancer
University of Texas Southwestern Medical Center 2
Large-scale testing (Phase 3)WithdrawnNCT04203511
What this trial is testing

INCMGA00012 in Combination With Chemoradiation in Participants With Stage III Non-Small Cell Lung Cancer (POD1UM-301)

Who this might be right for
Non-small Cell Lung Cancer
Incyte Corporation
Next Page